PaxMedica is a clinical-stage biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders. Our lead programs are focused on two of the world’s most challenging conditions – Autism Spectrum Disorder (ASD) and Fragile X-Associated Tremor/Ataxia (FXTAS). There are no FDA-approved treatments for the core symptoms of ASD and no FDA-approved treatments at all for FXTAS. We are on a promising path to change that.
You may communicate with Paxmedica's Board of Directors by sending an email to email@example.com.
Communications are distributed to the Board of Directors, or to any individual directors as is appropriate, depending on the facts and circumstances outlined in the communication.
Typically, Paxmedica does not forward communications that are of a personal nature or unrelated to the duties and responsibilities of the Board, including:
In addition, material that is unduly hostile, threatening, illegal, or similarly unsuitable will be excluded, with the provision that any communication that is filtered out must be made available to any non-management director upon request.
PaxMedica went public in August 2022.
PaxMedica is listed on NASDAQ and trades under the ticker symbol “PXMD”.
PaxMedica does not currently pay dividends on its common stock.
No, please contact a licensed stockbroker or an online trading company for any common stock transactions.
PaxMedica’s CUSIP number is 70424C 104.
PaxMedica is incorporated in Delaware.
PaxMedica’s corporate headquarters are located at:
303 South Broadway
Tarrytown, NY 10591
PaxMedica’s fiscal year end is December 31st.
462 South 4th Street
Louisville, KY 40202
U.S. – (800) 736-3001
Non-U.S. – (781) 575-3100
Please contact the Company’s transfer agent, Computershare.
730 3rd Avenue
New York, NY 10017
For additional information please contact Investor Relations:
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia.